Dr. Stephen Hahn is returning to the field where he began his career as CEO of Nucleus RadioPharma, a company developing new radiopharmaceuticals that target cancer cells with precision and reduce harm to healthy tissues.
Source: https://www.statnews.com/2025/08/20/nucleus-radiopharma-stephen-hahn